Davis G L, Hoofnagle J H, Waggoner J G
Gastroenterology. 1984 Feb;86(2):230-5.
Studies on the natural history of chronic type B hepatitis have shown that loss of hepatitis B e antigen and seroconversion to antibody to hepatitis B e antigen are usually accompanied by remission of disease activity and improvement in serum aminotransferase levels. Twenty-five symptomatic patients with biopsy-documented chronic type B hepatitis were followed for 25 +/- 2 mo (mean +/- SEM) after disappearance of hepatitis B e antigen, hepatitis B virus-deoxyribonucleic acid, and deoxyribonucleic acid polymerase activity from the serum. Twenty-four patients developed the antibody to hepatitis B e antigen. All 25 patients demonstrated a decrease in serum aminotransferase levels, and most became asymptomatic. However, during subsequent follow-up, 8 of the 25 patients (32%) exhibited reactivation of chronic type B hepatitis manifested by abrupt elevation of serum aminotransferase levels and reappearance of serum hepatitis B virus-deoxyribonucleic acid, deoxyribonucleic acid polymerase activity, and, in 7 patients, hepatitis B e antigen. All 8 patients developed symptoms: 3 became icteric, 3 developed ascites, and 2 bled from esophageal varices. One of these patients died. Episodes of reactivation invariably occurred within 1 yr of loss of hepatitis B e antigen and lasted for up to 13 mo. These observations suggest that loss of hepatitis B e antigen and seroconversion to the antibody to hepatitis B e antigen do not necessarily imply permanent remission of chronic type B hepatitis, and subsequent spontaneous reactivation may be an important cause of progression of hepatic injury.
对慢性乙型肝炎自然史的研究表明,乙肝e抗原消失并血清转化为乙肝e抗体通常伴随着疾病活动缓解和血清转氨酶水平改善。25例经活检证实的慢性乙型肝炎症状性患者在血清中乙肝e抗原、乙肝病毒脱氧核糖核酸及脱氧核糖核酸聚合酶活性消失后接受了25±2个月(均值±标准误)的随访。24例患者出现了乙肝e抗体。所有25例患者血清转氨酶水平均下降,且多数患者无症状。然而,在随后的随访中,25例患者中有8例(32%)出现慢性乙型肝炎再激活,表现为血清转氨酶水平突然升高,血清乙肝病毒脱氧核糖核酸、脱氧核糖核酸聚合酶活性再现,7例患者乙肝e抗原再现。所有8例患者均出现症状:3例出现黄疸,3例出现腹水,2例因食管静脉曲张出血。其中1例患者死亡。再激活发作均发生在乙肝e抗原消失后的1年内,持续时间长达13个月。这些观察结果提示,乙肝e抗原消失及血清转化为乙肝e抗体并不一定意味着慢性乙型肝炎的永久缓解,随后的自发再激活可能是肝损伤进展的一个重要原因。